Sort
21,453 grants matching “tuberculosis”
Biostatistics and Data Management Resource Core
$280,048Debbie M Cheng · Boston Medical Center · P01 · FY2021 · AA
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa
$280,026Max O'Donnell · Columbia University Health Sciences · R01 · FY2025 · AI
South Africa Tuberculosis AIDS Training (SATBAT)
$279,984Neil A Martinson · Wits Health Consortium (Pty), Ltd · U2R · FY2007 · TW
Task 4: The Interventional Agent Development Services program
$279,961Jon Carl Mirsalis · Sri International · N01 · FY2014 · AI
Functional analysis of the MbtH-like protein superfamily
$279,809Michael G Thomas · University Of Wisconsin-Madison · R01 · FY2016 · GM
Functional analysis of the MbtH-like protein superfamily
$279,809Michael G Thomas · University Of Wisconsin-Madison · R01 · FY2015 · GM
Functional analysis of the MbtH-like protein superfamily
$279,809Michael G Thomas · University Of Wisconsin-Madison · R01 · FY2014 · GM
Transforming Primary Care Practice
$279,735David L. Driscoll · University Of Alaska Anchorage · R18 · FY2011 · HS
Inhibition of Macrophage Innate Immunity in Tuberculosis
$279,713William Michael Nauseef · University Of Iowa · R01 · FY2007 · AI
SQUALENE AND OXIDOSQUALENE CYCLASES
$279,578University Of Utah · R01 · FY2001 · GM
Functional phosphosignaling in Mtb infection
$279,531Christoph Grundner · Seattle Children'S Hospital · R21 · FY2020 · AI
The roles of biologically relevant ncRNAs
$279,487Sarah M Fortune · Harvard School Of Public Health · U19 · FY2015 · AI
Bioinformatics Core
$279,442Soumya Raychaudhuri · Brigham And Women'S Hospital · U19 · FY2021 · AI
Targeting the sphingolipid pathway for the R&D of new antifungals
$279,393Maurizio Del Poeta · Microrid Technologies, Inc. · R41 · FY2018 · AI
NOVEL CONTROL MECHANISMS IN ENDOSPORE FORMATION
$279,387Robert L Switzer · University Of Illinois At Urbana-Champaign · R01 · FY2006 · GM
Targeting an immunomodulatory protease for adjunctive tuberculosis chemotherapy
$279,358Jyothi Rengarajan · Emory University · R21 · FY2015 · AI
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
$279,125University Of Rochester · R01 · FY2004 · AI
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
$279,125University Of Rochester · R01 · FY2003 · AI
BIOSYNTHESIS OF THE MYCOBACTERIAL PEPTIDOGLYCAN
$279,125University Of Rochester · R01 · FY2001 · AI
Structure and Mechanism in the Tautomerase Superfamily
$279,111Christian P. Whitman · University Of Texas At Austin · R01 · FY2009 · GM
Structure and Mechanism in the Tautomerase Superfamily
$279,111Christian P. Whitman · University Of Texas At Austin · R01 · FY2008 · GM
RC#2: Macrophage Oxidant Stress and Dysfunction
$279,030Lou Ann S. Brown · Emory University · P50 · FY2010 · AA
Th1-to Th2 shift of HSP65 responses and atherogenesis
$279,000East Carolina University · R01 · FY2002 · HL
Differential IL-2 Expression by Effector CD8 T cells and Fate Determination
$279,000Vandana Kalia · Seattle Children'S Hospital · R21 · FY2021 · AI
Improved Methods for Membrane Protein Crystallization
$278,913Michael C. Wiener · University Of Virginia · R01 · FY2006 · GM